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OBJECTIVES: 
To evaluate the role of serial diffusion weighted magnetic resonance imaging (DW-MRI) 
for predicting clinical and pathologic response to neoadjuvant chemoradiotherapy in 
esophageal cancer. 
METHODS: 
This is a prospective cohort study conducted in our institution comprising 24 
consecutive patients with biopsy proven, locally advanced esophageal cancer who were 
planned for neoadjuvant chemoirradiation. All the recruited patients underwent a baseline 
DW-MRI, another at 10 to14 days and another at the end of radiation. During assessment 
for surgery, the patients who were deemed surgically inoperable were called as non-
responders. Among those who underwent surgery, patients with complete pathological 
response (pCR) were called responders whereas those with a poor response were called 
as non-responders. The Apparent Diffusion Coefficient (ADC) values (mean and 
minimum) and the ΔADC values were calculated. 
RESULTS : 
The ADC values measured in the interim scan was significantly higher among 
patients with pathological complete response compared to the non-responders (mean 
p=0.013, minimum p=0.001). However, the ΔADC values did not significantly correlate 
with the pathological response. Hence, it was concluded that serial DW-MRIs performed 
in patients undergoing chemoradiotherapy is feasible and may be used to predict 
treatment response at surgery. Also, a significant rise in ADC values in the interim scan 
obtained at 10-14 days, may predict a pathological complete response at surgery. 
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